BeStock  

AtriCure ATRC

US equityMarket cap rank #2483Medical Instruments & Supplies
$55.39 +$1.28 (+2.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $55.39 0.00%
Open$54.03
Prev close$54.11
Day range$54.03 – $56.19
Volume813.1K
Market cap$2.82B
P/E (TTM)178.7
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$154.45M+15.0% YoY
Operating profit$4.35M+1,992.8% YoY
Net profit$4.06M+1,622.1% YoY
Diluted EPS$0.08+900.0% YoY
Free cash flow$19.43M-19.4% YoY
Operating cash flow$30.32M

Revenue, last 8 quarters

$124.3MDec '24$123.6MMar '25$136.1MJun '25$134.3MSep '25$140.5MDec '25$141.2MMar '26$153.6MJun '26$154.5MSep '26

Net profit, last 8 quarters

$-15.6MDec '24$-6.7MMar '25$-6.2MJun '25$-267.0KSep '25$1.8MDec '25$108.0KMar '26$9.0MJun '26$4.1MSep '26

Diluted EPS by quarter

-0.33Dec '24-0.14Mar '25-0.13Jun '25-0.01Sep '250.04Dec '250.00Mar '260.18Jun '260.08Sep '26

Free cash flow by quarter

$-8.9MDec '24$-13.2MMar '25$14.0MJun '25$24.1MSep '25$17.4MDec '25$-7.8MMar '26$18.4MJun '26$19.4MSep '26

Annual revenue

$206.5MFY20$274.3MFY21$330.4MFY22$399.2MFY23$465.3MFY24$534.5MFY25

Profitability & balance sheet

Gross margin76.7%
Operating margin2.9%
Net margin2.5%
Return on equity2.9%
Return on assets2.2%
Return on invested capital2.6%
Current ratio4.33
Liabilities / assets25.7%
Cash & investments$187.03M
Total debt$93.11M
Net cash (debt)$93.93M
Free cash flow / sales8.0%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Appendage management$62.48M 40.5%
  • Open ablation$54.18M 35.1%
  • Pain management$30.50M 19.7%
  • Minimally invasive ablation$7.29M 4.7%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $154.45M $153.60M $141.25M $534.53M $140.50M
Total Operating Revenue $154.45M $153.60M $141.25M $534.53M $140.50M
Cost of Revenue $35.10M $34.98M $31.94M $133.75M $35.16M
Gross Profit $119.35M $118.63M $109.31M $400.78M $105.34M
Operating Expense $115.00M $108.96M $108.79M $410.23M $102.85M
Selling and Admin Expenses $82.88M $82.56M $84.55M $311.02M $78.34M
Research & Development $32.12M $26.40M $24.24M $99.21M $24.51M
Operating Profit $4.35M $9.67M $526,000.00 -$9.45M $2.49M
Net Non-Operating Interest Income (Expense) -$213,000.00 -$139,000.00 -$95,000.00 -$1.40M -$173,000.00
Non-Operating Interest Income $1.40M $1.18M $1.25M $4.48M $1.33M
Non-Operating Interest Expense $1.61M $1.32M $1.34M $5.88M $1.50M
Other Income (Expense) -$123,000.00 -$100,000.00 -$37,000.00 $683,000.00 $42,000.00
Other Non-Operating Income (Expenses) -$123,000.00 -$100,000.00 -$37,000.00 $683,000.00 $42,000.00
Pretax Profit $4.02M $9.43M $394,000.00 -$10.16M $2.36M
Tax -$47,000.00 $471,000.00 $286,000.00 $1.29M $604,000.00
Net Profit $4.06M $8.96M $108,000.00 -$11.45M $1.76M
Profit from Continuing Operations $4.06M $8.96M $108,000.00 -$11.45M $1.76M
Net Income to Parent Company $4.06M $8.96M $108,000.00 -$11.45M $1.76M
Net Income to Common Stockholders $4.06M $8.96M $108,000.00 -$11.45M $1.76M
Basic EPS $0.08 $0.18 $0.00 -$0.24 $0.04
Diluted EPS $0.08 $0.18 $0.00 -$0.24 $0.04
Special Income (Charges) – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $717.54M $676.64M $643.99M $654.18M $654.18M
Total Current Assets $363.39M $345.53M $313.69M $322.52M $322.52M
Cash and Cash Equivalents & Short-Term Investments $187.03M $167.79M $146.17M $167.43M $167.43M
-Cash and Cash Equivalents $187.03M $167.79M $146.17M $167.43M $167.43M
Receivables $76.13M $79.98M $71.31M $66.65M $66.65M
-Accounts Receivable $76.13M $79.98M $71.31M $66.65M $66.65M
Inventory $87.31M $83.93M $81.14M $78.49M $78.49M
Other Current Assets $12.92M $13.84M $15.07M $9.94M $9.94M
Total Non-Current Assets $354.15M $331.11M $330.30M $331.66M $331.66M
Net PPE $72.38M $48.49M $46.19M $45.99M $45.99M
-Gross PPE $72.38M $48.49M $46.19M $115.76M $115.76M
Goodwill and Other Intangible Assets $275.66M $278.04M $280.42M $282.81M $282.81M
-Goodwill $234.78M $234.78M $234.78M $234.78M $234.78M
-Other Intangible Assets $40.88M $43.26M $45.64M $48.03M $48.03M
Other Non-Current Assets $6.11M $4.58M $3.69M $2.86M $2.86M
Total Liabilities $184.31M $160.21M $152.30M $162.24M $162.24M
Total Current Liabilities $83.97M $81.92M $73.19M $81.52M $81.52M
Payables $30.39M $35.85M $30.56M $25.31M $25.31M
-Accounts Payable $30.39M $35.85M $30.56M $25.31M $25.31M
Current Accrued Expenses $3.50M $3.30M $3.28M $2.85M $2.85M
Current Provisions $4.01M $4.01M $3.97M $3.48M $3.48M
Other Current Liabilities $3.73M $3.17M $3.13M $3.12M $3.12M
Total Non-Current Liabilities $100.34M $78.29M $79.10M $80.72M $80.72M
Long Term Debt and Capital Lease Obligation $93.11M $71.05M $71.78M $73.38M $73.38M
-Long Term Debt $61.00M $61.00M $61.00M $61.87M $61.87M
-Long Term Capital Lease Obligation $32.11M $10.05M $10.78M $11.52M $11.52M
Other Non-Current Liabilities $7.24M $7.25M $7.32M $7.34M $7.34M
Total Equity $533.22M $516.43M $491.69M $491.94M $491.94M
Stockholders' Equity $533.22M $516.43M $491.69M $491.94M $491.94M
Capital Stock $51,000.00 $51,000.00 $51,000.00 $50,000.00 $50,000.00
-Common Stock $51,000.00 $51,000.00 $51,000.00 $50,000.00 $50,000.00
Additional Paid-In Capital $933.23M $920.42M $904.51M $904.52M $904.52M
Retained Earnings -$400.08M -$404.14M -$413.10M -$413.20M -$413.20M
Gains/Losses Not Affecting Retained Earnings $15,000.00 $101,000.00 $227,000.00 $566,000.00 $566,000.00
-Accumulated Depreciation – – – -$69.77M -$69.77M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $30.32M $22.19M -$4.00M $57.33M $20.03M
Net cash flow from continuing operations $30.32M $22.19M -$4.00M $57.33M $20.03M
Net Income from Continuing Operations $4.06M $8.96M $108,000.00 -$11.45M $1.76M
Depreciation & Depletion & Amortization $5.48M $5.31M $5.27M $20.53M $5.11M
Other Non-Cash Items $5.16M $574,000.00 $813,000.00 $7.85M $1.77M
Change in Working Capital $3.14M -$4.96M -$21.46M -$4.29M $137,000.00
-Change in Receivables $3.78M -$8.76M -$5.02M -$5.61M -$3.76M
-Change in Inventory -$3.44M -$2.87M -$2.77M -$2.26M $455,000.00
-Change in Payables and Accrued Expense $3.88M $6.89M -$7.94M $6.04M $2.43M
-Change in Other Current Assets $903,000.00 $1.20M -$5.16M -$328,000.00 $1.36M
-Change In Other Working Capital -$1.98M -$1.42M -$575,000.00 -$2.13M -$352,000.00
Net cash flow from investing -$10.89M -$3.77M -$3.85M -$14.55M -$2.60M
Net Cash Flow from Continuing Investing Activities -$10.89M -$3.77M -$3.85M -$14.55M -$2.60M
Net PPE Purchase and Sale -$6.39M -$3.77M -$3.85M -$9.05M -$1.60M
Net Intangibles Purchase and Sale -$4.50M – – -$6.00M -$1.00M
Financing Cash Flow -$26,000.00 $3.26M -$13.26M $1.18M $2.10M
Net Cash Flow from Continuing Financing Activities -$26,000.00 $3.26M -$13.26M $1.18M $2.10M
Net Issuance Payments Of Debt -$326,000.00 -$334,000.00 -$1.19M -$1.20M -$321,000.00
Net Common Stock Issuance -$543,000.00 -$314,000.00 -$11.44M -$11.16M -$228,000.00
Cash Dividends Paid $0.00 $0.00 $0.00 $0.00 $0.00
Proceeds from Stock Option Exercised $877,000.00 $3.91M $158,000.00 $7.29M $2.65M
Ending Cash Balance $187.03M $167.79M $146.17M $167.43M $167.43M
Net Change in Cash $19.41M $21.69M -$21.10M $43.96M $19.52M
Beginning Cash Balance $167.79M $146.17M $167.43M $122.72M $147.87M
Effect of Exchange Rate Changes -$163,000.00 -$67,000.00 -$160,000.00 $747,000.00 $40,000.00
Free Cash Flow $19.43M $18.43M -$7.85M $42.28M $17.43M
Net Investment Purchase and Sale – – – $0.00 $0.00
Net Other Investing Changes – – – $500,000.00 $0.00
Net Other Financing Charges – – – $6.25M $0.00

Discussion

No comments yet — be the first to weigh in on ATRC.

Sign in to join the discussion.

Scroll to Top